Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy? -- Ignore unavailable to you. Want to Upgrade?

To: Bill Wexler who wrote (4774)	7/12/1998 1:24:00 AM
From: Brander	Read Replies (3) \| Respond to of 7041

Bill, you are speaking beyond your accountant expertise. You said: "Problem is that oral phentolamine is hardly "fast acting" " . Depending on the formulation, medications can be made to absorb slow or fast. It is certainly feasible that a fast acting form of oral phentolamine could be formulated. Also, you said that the clinical trials do not support that oral phentolamine is more effective than placebo in treating ED. This is false, and, again, I don't believe you are qualified to correctly interpret scientific data. The data do support the hypothesis that the drug tested (Vasomax) is more effective than placebo in treating ED in the patient population tested. Do you really think SGP would have anything to do with it if it didn't? Also, calling me a shill proves your lack of insight and ignorance. I have never had a position in ZONA, and I have nothing to do with the company. I am interested in ED as a professional, and I do have a position in Pfizer. Also, as a physician, I would like to have Vasomax available for patients, if it turns out to be an effective medication. I also have a strong interest in keeping the medical facts straight. You are distorting them, and you are not qualified to interpret them.